Semi-Annual Consolidated Statement Of Cash Flows

JCR Pharmaceuticals Co.,Ltd. - Filing #7360123

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,762,000,000 JPY
11,817,000,000 JPY
Interest and dividends received
62,000,000 JPY
35,000,000 JPY
Interest paid
-46,000,000 JPY
-45,000,000 JPY
Net cash provided by (used in) operating activities
-5,500,000,000 JPY
9,289,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-7,654,000,000 JPY
-11,333,000,000 JPY
Other, net
15,000,000 JPY
-9,000,000 JPY
Net cash provided by (used in) investing activities
-15,002,000,000 JPY
-3,250,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
4,750,000,000 JPY
750,000,000 JPY
Repayments of long-term borrowings
-3,050,000,000 JPY
-750,000,000 JPY
Dividends paid
-2,739,000,000 JPY
-2,169,000,000 JPY
Net cash provided by (used in) financing activities
1,948,000,000 JPY
-2,179,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,099,000,000 JPY
612,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-17,454,000,000 JPY
4,472,000,000 JPY
Cash and cash equivalents
13,278,000,000 JPY
30,733,000,000 JPY
26,260,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.